Browsing "1. Journal Papers" by Author : 298

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 60 of 86

This table browses all dspace content
Issue DateTitleJournal Title
2007A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiationINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2007A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and ... CANCER RESEARCH AND TREATMENT
2011A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy CANCER
2022A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer NATURE COMMUNICATIONS
2010Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticatorsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2006Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancerONCOLOGY REPORTS
2007An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients ONCOLOGIST
2008Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma. MOLECULAR CANCER RESEARCH
2013Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic ToolANNALS OF SURGICAL ONCOLOGY
2007Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters JAPANESE JOURNAL OF CLINICAL ONCOLOGY
1999Changes of telomerase and telomere lengths in paired normal and cancer tissues of breastInternational Journal of Oncology
2009Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma ANNALS OF ONCOLOGY
2009Clinical value of ezrin expression in primary osteosarcoma CANCER RESEARCH AND TREATMENT
2015Clinicopathological features and prognostic significance of HER2 expression in gastric cancerONCOLOGY
1999Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcomaONCOLOGY REPORTS
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy ONCOTARGET
2000Correlation of tissue and blood plasminogen activation system in breast cancerJournal of Neurology, Neurosurgery and Psychiatry
2008Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancerARCHIVES OF SURGERY
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab ONCOTARGET
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2007Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancerBREAST CANCER RESEARCH AND TREATMENT
1998Different expression patterns of MMP-2 and MMP-9 in breast cancerONCOLOGY REPORTS
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia ANNALS OF SURGERY
2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement CANCER
2024Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial NATURE COMMUNICATIONS
2015Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series BMC CANCER
2001Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities CANCER RESEARCH AND TREATMENT
2013Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY
2016Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma. YONSEI MEDICAL JOURNAL
2011Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastasesINVESTIGATIVE RADIOLOGY
2007Gastrointestinal stromal tumor of the rectum: An analysis of seven casesSURGERY TODAY
2005Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2007Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization BMC GENOMICS
2011Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis.ONCOLOGY REPORTS
2022Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancerEUROPEAN JOURNAL OF CANCER
2007Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancerGENOMICS
2013Identifying genes related to radiation resistance in oral squamous cell carcinoma cell linesINTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2015Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children CANCER RESEARCH AND TREATMENT
2003Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinomaEUROPEAN UROLOGY
2009Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancerJOURNAL OF SURGICAL ONCOLOGY
2006Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNACANCER SCIENCE
2004Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell LymphomasLEUKEMIA & LYMPHOMA
2019Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Cancer Research and Treatment
2015Leiomyosarcoma: investigation of prognostic factors for risk-stratification modelINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2006Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports CANCER RESEARCH AND TREATMENT
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2018MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.JOURNAL OF SURGICAL ONCOLOGY
2007Molecular basis of the differences between normal and tumor tissues of gastric cancerBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
2022Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysisJOURNAL OF CLINICAL ONCOLOGY
2005Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis ANNALS OF ONCOLOGY
2010Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis. CANCER RESEARCH AND TREATMENT
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyJOURNAL OF CLINICAL ONCOLOGY
2012Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy PLOS ONE
2021p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancerBIOCHEMICAL PHARMACOLOGY
2022Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaCLINICAL CANCER RESEARCH
2014Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneCANCER CHEMOTHERAPY AND PHARMACOLOGY
2010Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
12

Browse

Links